Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis

被引:16
作者
Dannaoui, E
Colin, S
Pichot, J
Piens, MA
机构
[1] Univ. Claude Bernard Lyon I, Lab. de Parasitol. et Mycologie Med., 69383 Lyon Cedex 08
关键词
D O I
10.1007/BF01709586
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of the present study was to evaluate the utility of the E test in determining the antifungal susceptibility of Candida albicans, Reproducibility of the E test was determined for amphotericin B, fluconazole, and itraconazole using three different solid media: RPMI 1640, Casitone, and yeast nitrogen base agar, Minimum inhibitory concentrations (MICs) were comparable (results at +/-2 dilutions) in 92% of the tests for amphotericin B and in 100% for fluconazole and itraconazole, Determination of MIC endpoints was easiest on Casitone agar, Candida albicans isolates from 23 patients undergoing fluconazole therapy for oropharyngeal candidiasis were tested for fluconazole susceptibility, Good correlation was obtained between the MICs of fluconazole and clinical outcome, Clinical failure was associated with strains for which MICs were greater than or equal to 48 mu g/ml. These results suggest that the E test has potential utility for fluconazole susceptibility testing of clinical yeast isolates.
引用
收藏
页码:228 / 232
页数:5
相关论文
共 16 条
[1]   COMPARISON OF E-TEST AND NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS BROTH MACRODILUTION METHOD FOR AZOLE ANTIFUNGAL SUSCEPTIBILITY TESTING [J].
COLOMBO, AL ;
BARCHIESI, F ;
MCGOUGH, DA ;
RINALDI, MG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :535-540
[2]  
Espinel-Ingroff Ana, 1995, P1405
[3]   COMPARISON STUDY OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS [J].
ESPINELINGROFF, A ;
KERKERING, TM ;
GOLDSON, PR ;
SHADOMY, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (06) :1089-1094
[4]   Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose [J].
EspinelIngroff, A ;
Pfaller, M ;
Erwin, ME ;
Jones, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :848-852
[5]   ETEST FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS [J].
ESPINELINGROFF, A .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (04) :217-220
[6]   Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome [J].
Ghannoum, MA ;
Rex, JH ;
Galgiani, JN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :489-495
[7]   FLUCONAZOLE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN MAJOR SUPERFICIAL AND SYSTEMIC MYCOSES IN IMMUNOCOMPROMISED PATIENTS [J].
GOA, KL ;
BARRADELL, LB .
DRUGS, 1995, 50 (04) :658-690
[8]   RESISTANCE OF CANDIDA-ALBICANS TO AZOLE ANTIFUNGAL AGENTS [J].
HITCHCOCK, CA .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (04) :1039-1047
[9]  
*NAT COMM CLIN LAB, 1992, REF METH BROTH DIL A
[10]   Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates [J].
Pfaller, MA ;
Messer, SA ;
Bolmstrom, A ;
Odds, FC ;
Rex, JH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1691-1693